Refine by
Risk Assessment Equipment Supplied In Usa Texas
6 equipment items found
by:Accruent based inAustin, TEXAS (USA)
Manage attributes of all network connected medical devices. Conduct risk assessments, reconcile MDS2 data and other security attributes against inventory, and remediate potential risks and vulnerabilities. Automate workflows unique to your ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Empower screens for genes associated with increased risk for common hereditary cancers. Our Empower multi-cancer panels include commonly screened-for genes associated with 12+ types of ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Covered by Medicare, Prospera is a transplant rejection assessment test that uses a simple blood draw to evaluate the risk of rejection of a transplanted kidney. Through the use of advanced cell-free DNA technology, Prospera increases a provider’s ability to identify otherwise undetected rejection that might lead to kidney loss. ...
Manufactured by:Millar based inHouston, TEXAS (USA)
Utilizing two tonometers to derive pulse wave velocity (PWV) offers an analysis of arterial stiffness, a crucial metric in assessing risks for heart disease, stroke, and dementia. The tonometer aids in the examination of the augmentation index, pressure augmentation, and reflected wave magnitude, offering comprehensive cardiovascular evaluations. This precision ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer ...